commented, "Entering the K-Pharmacy channel is not just about distribution—it reflects a level of trust earned through formulation expertise and product performance. We will continue to strengthen our presence in professional channels to further...
with neurological conditions, announced its official launch. The company is advancing a proprietary neural interface platform designed to translate brain signals into actionable digital commands, enabling rehabilitation and assistive therapies for...
investigators Bobo Dang and Ting Zhou at Westlake University/Westlake Laboratory reported in Science a high-throughput platform for engineering fast-acting covalent protein therapeutics. Their work, titled "A high-throughput selection system for...
for Open Innovation Bridging Human, Environment and Materials. The aim objective of ICCBS 2026 is to provide a platform for researchers, engineers, academicians as well as industrial professionals from all over the world to present their research...
to support consistent, patient-friendly dressing changes. By providing the necessary materials in a single, easy-to-use format, carePAC™ aims to reduce complexity for patients and caregivers while supporting adherence to provider-directed wound...
Fisher Scientific the world leader in serving science, announced a next-generation, integrated cell line development platform that enables biologics developers to accelerate time to clinic while maintaining regulatory confidence and commercial...
Orca Bio, a late-stage biotechnology company committed to transforming the lives of patients through high-precision cell therapy, announced that the U.S. Food and Drug Administration (FDA) has extended the review timeline of its Biologics License...
following bispecifics or other BCMA-directed therapies have very limited options. We believe InoPd may deliver a transformative all-oral treatment for RRMM patients and look forward to further evaluating its potential in this Phase 2 trial.” Care...
medicines. He has a strong track record in leading global organizations, scaling operations and driving strategic transformation in complex healthcare environments. Most recently, he served as Group CEO of Pharmanovia, where he led a major...
MVM Partners announced in November 2025, Avanzanite is scaling its European infrastructure into a single, integrated platform across 32 countries – designed to bring rare disease medicines to patients in every European market. “France is essential...
and motor control by replacing neurons lost to the disease, with the goal of achieving functional restoration. For more information please Visit www.oryoncelltherapies.com
Support Office. This structural control is further underscored by the fact that Samsung Biologics' top HR executive is a former Samsung Electronics official. President Park emphasized, "Even if the working-level negotiators attempt to reach a...
companies will be invaluable.” “Convergent has a world-class leadership team and has built one of the most compelling platforms in prostate cancer with an approach that harnesses antibodies as precision delivery vehicles for Ac-225 and could...
options to personalize treatment plans for each patient." "As the leader in hematology, we have a proud history of transforming the treatment landscape for multiple myeloma. This approval represents another pivotal milestone in improving outcomes...
is launching a U.S.-based Clinical Research Program designed to generate clinical evidence supporting product safety, performance, and patient outcomes across global markets. Calaway brings more than 17 years of experience in clinical operations,...
efforts ahead of anticipated market entry in 2027. The Series C will also support advancement of the Spectris platform into additional neurodegenerative indications through their network of brain health collaboratories beginning with WVU...
cases, infantile hemangiomas can lead to serious complications including loss of vision, trouble breathing, or physical deformities, and require intervention with systemic therapy. Treatment with HEMANGEOL is typically initiated between ages five...
year of policy debate. They mark a structural shift where employer governance and market pressure converge to force reform. US-Rx Care advises plan sponsors that they can no longer rely on traditional PBM contracting models and must proactively...
at an advanced stage. About Merck’s research in genitourinary cancers Merck is advancing research aimed at helping transform the treatment landscape and broaden options for people with genitourinary (GU) cancers, including bladder, kidney and...
against novel targets in cancer and other immune-related diseases. Powered by its proprietary 3T-TRACE™ discovery platform, the company integrates high-diversity experimental libraries with advanced machine learning to systematically identify...
